ERIC W GERSTENBERG, the CO-CEO of $CLH, sold 601 shares of the company on 12-16-2025 for an estimated $144,780. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.2% of their shares of this class of stock. Following this trade, they now own 50,454 shares of this class of $CLH stock.
$CLH Insider Trading Activity
$CLH insiders have traded $CLH stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CLH stock by insiders over the last 6 months:
- MICHAEL LOUIS BATTLES (CO-CEO) purchased 2,000 shares for an estimated $467,000
- ANDREA ROBERTSON sold 836 shares for an estimated $195,323
- ERIC W GERSTENBERG (CO-CEO) sold 601 shares for an estimated $144,780
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLH Hedge Fund Activity
We have seen 246 institutional investors add shares of $CLH stock to their portfolio, and 322 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D1 CAPITAL PARTNERS L.P. added 1,001,946 shares (+69.4%) to their portfolio in Q3 2025, for an estimated $232,671,900
- DURABLE CAPITAL PARTNERS LP added 573,666 shares (+inf%) to their portfolio in Q3 2025, for an estimated $133,216,718
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 519,780 shares (+72.2%) to their portfolio in Q3 2025, for an estimated $120,703,311
- NORDEA INVESTMENT MANAGEMENT AB added 471,206 shares (+inf%) to their portfolio in Q3 2025, for an estimated $109,423,457
- GOLDMAN SACHS GROUP INC added 242,177 shares (+371.5%) to their portfolio in Q3 2025, for an estimated $56,238,342
- CITADEL ADVISORS LLC removed 240,240 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $55,788,532
- TWO SIGMA INVESTMENTS, LP added 229,666 shares (+148.3%) to their portfolio in Q3 2025, for an estimated $53,333,038
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLH Revenue
$CLH had revenues of $1.5B in Q3 2025. This is an increase of 1.3% from the same period in the prior year.
You can track CLH financials on Quiver Quantitative's CLH stock page.
$CLH Congressional Stock Trading
Members of Congress have traded $CLH stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CLH stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 08/07, 06/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CLH Analyst Ratings
Wall Street analysts have issued reports on $CLH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Raymond James issued a "Strong Buy" rating on 10/30/2025
- Oppenheimer issued a "Outperform" rating on 07/31/2025
- BMO Capital issued a "Outperform" rating on 07/31/2025
To track analyst ratings and price targets for $CLH, check out Quiver Quantitative's $CLH forecast page.
$CLH Price Targets
Multiple analysts have issued price targets for $CLH recently. We have seen 8 analysts offer price targets for $CLH in the last 6 months, with a median target of $248.0.
Here are some recent targets:
- Bryan Burgmeier from Citigroup set a target price of $263.0 on 12/10/2025
- Adam Bubes from Goldman Sachs set a target price of $228.0 on 11/24/2025
- Jerry Revich from Wells Fargo set a target price of $220.0 on 11/14/2025
- Jon Windham from UBS set a target price of $240.0 on 10/31/2025
- William Grippin from Barclays set a target price of $230.0 on 10/30/2025
- Patrick Tyler Brown from Raymond James set a target price of $270.0 on 10/30/2025
- Noah Kaye from Oppenheimer set a target price of $256.0 on 07/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
